Evaluate Safety and Pharmacokinetic To Assess Bronchopulmonary Disposition of Intravenous Delafloxacin in Healthy Adults
Clinical trial NCT03534622 · COMPLETED
Trial details
- NCT number
- NCT03534622
- Sponsor
- Melinta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-30
- Primary completion
- 2018-07-19
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.